CRL · 8-K · 20261104PR000156
Guidance and Outlook
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-11-04 · Importance 82 · Surprise 100 · No source text
On November 4, 2026, Charles River raised its 2026 organic revenue growth guidance to at least 1.5%, from a prior range of 0.0%–1.0%. It increased non-GAAP EPS guidance to $11.35–$11.55 from $11.15–$11.45, and GAAP EPS guidance to $8.15–$8.35 from $3.05–$3.35. Management attributed the increase primarily to third-quarter outperformance, particularly in Discovery and Safety Assessment (DSA), and a lower tax rate; the GAAP EPS range also reflects the acquired-tax-reserve reversal. The reported revenue outlook includes a favorable foreign-exchange impact of 0.5%–1.0%, while the company expects approximately 4.5% contribution from divestitures.
Key facts
- 2026 organic revenue guidance increased by 100 basis points at the lower bound, from a prior range of 0.0%–1.0% to at least 1.5%. source
- 2026 reported revenue growth guidance is (2.0)% to (1.5)%, compared with prior guidance of (3.5)% to (2.5)%. source
- 2026 non-GAAP EPS guidance increased to $11.35–$11.55 from $11.15–$11.45, a $0.15 increase at the midpoint. source
- 2026 GAAP EPS guidance increased to $8.15–$8.35 from $3.05–$3.35. source
- The Company increased its 2026 revenue and EPS guidance, primarily reflecting third-quarter outperformance, particularly better-than-expected DSA performance and a lower tax rate. source
- 2026 GAAP EPS guidance includes a $5.03-per-share adjustment for reversal of acquired tax reserves. source
- 2026 guidance assumes approximately $4.70 per share of acquisition- and divestiture-related costs, compared with approximately $4.75 previously. source
- 2026 guidance includes approximately $1.50 per share of costs associated with restructuring and efficiency initiatives, compared with approximately $1.20 previously. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +1.3% | 2026 organic revenue guidance increased by 100 basis points at the lower bound, from a prior range of 0.0%–1.0% to at least 1.5%. |
| revenue | positive | committed | +1.1% | 2026 reported revenue growth guidance is (2.0)% to (1.5)%, compared with prior guidance of (3.5)% to (2.5)%. |
| net_income | positive | committed | — | 2026 non-GAAP EPS guidance increased to $11.35–$11.55 from $11.15–$11.45, a $0.15 increase at the midpoint. |
| net_income | positive | committed | — | 2026 GAAP EPS guidance increased to $8.15–$8.35 from $3.05–$3.35. |